Annmira Pharma India Private Limited
Founded in 2021 and headquartered in Kerala, India.
2021 | Ernakulam, Kerala (India) | Active
Annmira Pharma India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 10 Months
About Annmira Pharma India
Annmira Pharma India Private Limited (APIPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 April 2021 (Three years and ten months 27 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gisha Alphy, Remmi Chithambaran, Edayathuchirayil Rijo, and One other member serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299KL2021PTC068386
- Company No.
068386
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2021
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Chemicals
Who are the key members and board of directors at Annmira Pharma India?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gisha Alphy  | Director | 01-Apr-2021 | Current |
| Remmi Chithambaran | Director | 01-Apr-2021 | Current |
| Edayathuchirayil Rijo | Director | 01-Apr-2021 | Current |
| Sowmya | Director | 01-Apr-2021 | Current |
Financial Performance of Annmira Pharma India.
Enhance accessibility to Annmira Pharma India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Annmira Pharma India?
Unlock access to Annmira Pharma India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Annmira Pharma India?
Annmira Pharma India has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Annmira Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Annmira Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.